Members |
targetComponentId |
Beclomethasone dipropionate 8.4mg |
Product containing only beclometasone in pulmonary dose form (medicinal product form) |
Beclomethasone dipropionate 80mcg aerosol |
Product containing only beclometasone in pulmonary dose form (medicinal product form) |
Beclomethasone dipropionate 84mcg inhalation aerosol |
Product containing only beclometasone in pulmonary dose form (medicinal product form) |
Beclomethasone dipropionate+salbutamol |
Product containing beclometasone and salbutamol (medicinal product) |
Beclomethasone dipropionate+salbutamol 200micrograms/400micrograms inhalation capsule |
Product containing only beclometasone and salbutamol (medicinal product) |
Bedpan |
Bedpan |
Beetle |
Order Coleoptera (organism) |
Behavior disorder of childhood and adolescence |
Behavior problem of childhood and adolescence (finding) |
Bell-Buettner operation for subtotal abdominal hysterectomy |
Subtotal abdominal hysterectomy |
Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg m/r tablet |
Product containing only belladonna alkaloid and ergotamine and phenobarbital in oral dose form (medicinal product form) |
Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg prolonged-release oral tablet |
Product containing only belladonna alkaloid and ergotamine and phenobarbital in oral dose form (medicinal product form) |
Bemiparin sodium 22500iu/mL injection solution 0.3mL prefilled syringe |
Product containing precisely bemiparin sodium 22500 unit/1 milliliter conventional release solution for injection (clinical drug) |
Bemiparin sodium 40000iu/mL injection solution 0.4mL prefilled syringe |
Bemiparin sodium 40000 unit/mL solution for injection |
Bendamustine 100mg powder for injection solution 20ml vial |
Bendamustine hydrochloride 100 mg powder for solution for injection vial |
Benefits - other, specified |
Benefits and pensions |
Benefits - other, specified |
Benefits and pensions |
Benign adenomatous neoplasm - category |
Benign adenomatous neoplasm (morphologic abnormality) |
néoplasme carcinoïde bénin d'une bronche |
Carcinoid tumour of bronchus |
néoplasme carcinoïde bénin du gros intestin |
Well-differentiated neuroendocrine tumor of large intestine |
tumeur carcinoïde bénigne du poumon |
Carcinoid tumour of lung |
tumeur carcinoide bénigne |
Well-differentiated neuroendocrine tumour |
Benign carcinoid tumor |
Well-differentiated neuroendocrine tumor (morphologic abnormality) |
néoplasme carcinoïde bénin du tractus gastro-intestinal |
Well-differentiated neuroendocrine tumor of gastrointestinal tract |
néoplasme carcinoïde bénin du rein gauche |
Well-differentiated neuroendocrine tumor of left kidney (disorder) |
néoplasme carcinoïde bénin du foie |
Well-differentiated neuroendocrine tumor of liver |
néoplasme carcinoïde bénin du pancréas |
Neuroendocrine tumor of pancreas (disorder) |
néoplasme carcinoïde bénin du rein droit |
Well-differentiated neuroendocrine tumor of right kidney (disorder) |
épilepsie infantile bénigne non réfractaire avec pointes centrotemporales |
A common type of self-limited focal epilepsy syndrome, which begins typically between four and ten years (peak is seven years; range three to twelve years). Seizures are focal, infrequent (most children have fewer than ten in lifetime), brief (typically less than two to three minutes) and occur mostly in sleep (eighty to ninety percent of children). Individuals may have frequent seizures over a few days or weeks and then several months before subsequent seizure. Focal seizures with characteristic frontoparietal opercular features and/or nocturnal bilateral tonic-clonic seizures are mandatory for diagnosis. Characteristic semiology includes somatosensory symptoms (unilateral numbness or paresthesia of the tongue, lips, gums and inner cheek), orofacial motor signs (unilateral tonic or clonic contractions), speech arrest (dysarthria or anarthria) with preserved understanding, and sialorrhea. Seizures may evolve rapidly to tonic-clonic activity of the ipsilateral upper limb, to an ipsilateral hemiclonic seizure, or to a focal to bilateral tonic-clonic seizure. Todd paresis may occur postictally. Seizures occurring during sleep are seen within one hour of falling asleep or one to two hours prior to awakening. Development and cognition are typically normal. Neurological examination is normal. The electroencephalogram (EEG) background activity is normal. EEG must show centrotemporal biphasic epileptiform discharges which are characteristically high-amplitude complexes (less than 200 microvolts, peak to trough) that activate in drowsiness and sleep. MRI is normal or has nonspecific findings. |
Benign cyst of breast |
Cyst of breast (disorder) |
Benign epithelial neoplasm - category |
Benign epithelial neoplasm |
hypertension essentielle bénigne compliquant et/ou exigeant des soins pendant la puerpéralité |
Benign essential hypertension complicating pregnancy, childbirth and the puerperium |
hypertension essentielle bénigne compliquant la grossesse, l'accouchement et la puerpéralité avec complication postnatale |
Benign essential hypertension complicating pregnancy, childbirth and the puerperium |
Benign familial hematuria |
Thin basement membrane disease |
Benign fibrohistiocytic neoplasm - category |
Benign fibrohistiocytic neoplasm |
Benign fibromatous neoplasm - category |
Benign fibromatous neoplasm |
épilepsie bénigne frontale de l'enfance |
A type of focal epilepsy where all the seizures originate within the frontal lobe. |
insulinome bénin |
Malignant insulinoma |
Benign leiomyomatous neoplasm - category |
Leiomyoma |
Benign mammary dysplasia NOS |
Benign mammary dysplasia |
Benign mammary dysplasia NOS |
Benign mammary dysplasia |
Benign metastasizing leiomyoma of uterus |
Metastasizing leiomyoma of uterus (disorder) |
Benign neonatal seizures |
A type of self-limited focal epilepsy with onset typically between day two and seven of life. Seizures are focal tonic at onset, affecting the head, face, and limbs. Focal clonic or tonic seizures may evolve to bilateral tonic or clonic seizures. Onset may alternate between hemispheres. Autonomic features (apnea and cyanosis) are present in one third of seizures and may be the predominant manifestation. Seizure semiology may progress in a sequential pattern with tonic, clonic, myoclonic and autonomic features following each other without a single predominant feature. Clusters of seizures may occur over hours or days with the neonate behaving normally between events. Developmental progress is usually normal. The electroencephalogram (EEG) background is normal or has minor nonspecific abnormalities. Focal interictal epileptiform abnormalities can be seen in the central, centrotemporal or frontotemporal regions. MRI is normal or has nonspecific findings. Pathogenic variants are seen in KCNQ2, KCNQ3 and SCN2A. |
Benign neoplasm NOS |
Benign neoplastic disease (disorder) |
Benign neoplasm NOS |
Benign neoplastic disease (disorder) |
tumeur bénigne de l'aréole du sein de la femme |
Benign neoplasm of areola |
tumeur bénigne de l'aréole du sein de l'homme |
Benign neoplasm of areola |
néoplasme bénin de la queue axillaire du sein chez la femme |
Benign neoplasm of axillary tail of breast (disorder) |
tumeur bénigne de la partie centrale du sein |
Benign neoplasm of central portion of breast |
Benign neoplasm of connective and soft tissue of peritoneum |
Benign neoplasm of the peritoneum |
néoplasme bénin d'un tissu mammaire ectopique chez la femme |
Benign neoplasm of ectopic site of breast (disorder) |
néoplasme bénin d'un tissu mammaire ectopique chez l'homme |
Benign neoplasm of ectopic site of breast (disorder) |
Benign neoplasm of female breast |
Benign neoplasm of breast |
tumore benigno della mammella della donna |
Benign neoplasm of breast |
Benign neoplasm of ill-defined site |
Benign neoplastic disease (disorder) |
néoplasme bénin du sein féminin gauche |
Benign neoplasm of left breast (disorder) |
tumeur bénigne du quadrant inféro-interne du sein |
Benign neoplasm of lower inner quadrant of breast (disorder) |
tumeur bénigne du quadrant inféro-externe du sein |
Benign neoplasm of lower outer quadrant of breast (disorder) |
tumeur bénigne du sein de l'homme |
Benign neoplasm of breast |
Benign neoplasm of male breast |
Benign neoplasm of breast |
tumeur bénigne du mamelon de la femme |
Benign neoplasm of nipple (disorder) |
tumeur bénigne du mamelon de l'homme |
Benign neoplasm of nipple (disorder) |
Benign neoplasm of oral cavity NOS |
Benign neoplasm of oral cavity (disorder) |
Benign neoplasm of oral cavity NOS |
Benign neoplasm of oral cavity (disorder) |
Benign neoplasm of other specified sites of uterus |
Benign neoplasm of uterus |
néoplasme bénin du sein droit chez la femme |
Benign neoplasm of right breast (disorder) |
Benign neoplasm of skin (& various types) |
Benign neoplasm of skin |
tumeur bénigne du quadrant supéro-interne du sein |
Benign neoplasm of upper inner quadrant of breast |
tumeur bénigne du quadrant supéro-externe du sein |
Benign neoplasm of upper outer quadrant of breast (disorder) |
Benign neoplastic process |
Neoplasm, benign |
Benign nerve sheath tumor - category |
Benign nerve sheath tumor |
Benign neuroendocrine neoplasm - category |
Benign neuroendocrine neoplasm |
Benign neuroendocrine neoplasm of ascending colon |
Neuroendocrine neoplasm of ascending colon |
néoplasme neuroendocrine bénin de l'iléon |
Neuroendocrine neoplasm of ileum (disorder) |
néoplasme neuroendocrine bénin du jéjunum |
Neuroendocrine neoplasm of jejunum (disorder) |
néoplasme neuroendocrine bénin du gros intestin |
Neuroendocrine neoplasm of large intestine (disorder) |
néoplasme neuroendocrine bénin du pancréas |
Neuroendocrine neoplasm of pancreas (disorder) |
néoplasme neuroendocrine bénin du sigmoïde |
Neuroendocrine neoplasm of sigmoid colon |
Benign neuroendocrine neoplasm of transverse colon |
Neuroendocrine neoplasm of transverse colon (disorder) |
vertige de position paroxystique bénin et nystagmus |
Nystagmus due to benign paroxysmal positional vertigo |
Benign postural proteinuria |
Orthostatic proteinuria |
épilepsie psychomotrice bénigne de l'enfance |
A group of epilepsies characterized by age-dependent occurrence of drug responsive focal seizures in otherwise normal children. Seizures are focal motor or sensory with or without impaired awareness and may evolve to bilateral tonic-clonic seizures. Remission usually occurs by puberty. Development and cognition are typically normal. Neurological examination is normal. No significant structural lesions of the brain are present, and presumed genetic factors have an important role. The electroencephalogram (EEG) background activity is normal. Seizure semiology and EEG features are specific for each of the syndromes included in this group. |
Bennett respirator therapy |
Respiratory therapy |
Benoxinate hydrochloride 0.2% eye drops |
Oxybuprocaine only product |
Benoxinate hydrochloride 0.4% eye drops |
Oxybuprocaine only product |
Benoxinate hydrochloride+fluorescein sodium 0.3%/0.125% eye drops |
Product containing only fluorescein stain and oxybuprocaine in ocular dose form (medicinal product form) |
Benoxinate hydrochloride+fluorescein sodium 0.4%/0.25% ophthalmic solution |
Product containing only fluorescein stain and oxybuprocaine in ocular dose form (medicinal product form) |
test de rétention visuelle de Benton |
Benton visual retention test (assessment scale) |
Benzalkonium chloride (in water) |
Benzalkonium chloride |
Benzathine penicillin allergy |
Allergy to benzylpenicillin |
Benzhexol 2mg/5mL conventional release oral solution |
Product containing only trihexyphenidyl in oral dose form (medicinal product form) |
Benzhexol 2mg/5mL s/f oral solution |
Product containing only trihexyphenidyl in oral dose form (medicinal product form) |
Benzisoxazole derivative antipsychotic agent |
Benzisoxazole derivative |
Benzoate 1,2-dioxygenase |
Benzoate 1,2-dioxygenase |
Benzocaine + trimethobenzamide hydrochlor 2%ww/100mg suppositories |
Benzocaine and trimethobenzamide only product in rectal dose form |
Benzocaine + trimethobenzamide hydrochloride 2%ww/100mg rectal suppositories |
Benzocaine and trimethobenzamide only product in rectal dose form |
Benzocaine 20% otic drops |
Product containing precisely benzocaine 200 milligram/1 milliliter conventional release ear solution (clinical drug) |
Benzodiazepine sedative allergy |
Allergy to benzodiazepine |
Benzoic acid allergy |
Non-allergic hypersensitivity to benzoic acid |
Benzoyl peroxide |
Benzoyl peroxide |
Benzoyl peroxide + clindamycin phosphate |
Product containing benzoyl peroxide and clindamycin (medicinal product) |
Benzoyl peroxide + sulfur 10%ww/5%ww |
Product containing benzoyl peroxide and sulfur (medicinal product) |